Heather Heizer
YOU?
Author Swipe
View article: Sequential Intravenous-Oral Therapy for Pediatric <i>Streptococcus anginosus</i> Intracranial Infections
Sequential Intravenous-Oral Therapy for Pediatric <i>Streptococcus anginosus</i> Intracranial Infections Open
Background Streptococcus anginosus group is a common cause of pediatric intracranial infections but treatment recommendations, including use of oral therapy, are poorly defined. Methods We performed a retrospective review from 2004 to 2019…
View article: Temporal clustering of Kawasaki disease cases around the world
Temporal clustering of Kawasaki disease cases around the world Open
View article: 345. Early Oral Therapy for <i>Streptococcus anginosus</i> Purulent Brain Infections: A Single Center Experience
345. Early Oral Therapy for <i>Streptococcus anginosus</i> Purulent Brain Infections: A Single Center Experience Open
Background Pediatric Streptococcus anginosus intracranial pyogenic are commonly treated with prolonged intravenous (IV) antibiotics, exposing patients to risks of a long-term central catheter. Antibiotics with high oral bioavailability, su…
View article: Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm
Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm Open
View article: Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions Open
Background: We previously demonstrated that 80% of Kawasaki disease (KD) patients who develop coronary artery lesions (CALs) have them at diagnosis. We postulated that KD patients presenting with CALs represent a group that may benefit fro…
View article: Clinical Care Guideline for Improving Pediatric Acute Musculoskeletal Infection Outcomes
Clinical Care Guideline for Improving Pediatric Acute Musculoskeletal Infection Outcomes Open
Implementation of a CCG for acute musculoskeletal infections improves patient, process and resource outcomes.
View article: Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation
Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation Open
The range of strain found in our cohort was large. Improvement in mean strain was driven primarily by patients with lower initial strain. Lower strain was associated with increased markers of systemic inflammation, but not proximal coronar…
View article: Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions? Open
Additional research is needed to establish the sensitivity and specificity of PCT for the diagnosis of KD. PCT may be of value in predicting which children are at increased risk for IVIG-resistant disease.
View article: Pediatric Acute Musculoskeletal Infection Clinical Care Guideline Improves Outcomes
Pediatric Acute Musculoskeletal Infection Clinical Care Guideline Improves Outcomes Open